264 related articles for article (PubMed ID: 25947165)
21. Efficacy of a Plasmodium vivax malaria vaccine using ChAd63 and modified vaccinia Ankara expressing thrombospondin-related anonymous protein as assessed with transgenic Plasmodium berghei parasites.
Bauza K; Malinauskas T; Pfander C; Anar B; Jones EY; Billker O; Hill AV; Reyes-Sandoval A
Infect Immun; 2014 Mar; 82(3):1277-86. PubMed ID: 24379295
[TBL] [Abstract][Full Text] [Related]
22. Assessment of humoral immune responses to blood-stage malaria antigens following ChAd63-MVA immunization, controlled human malaria infection and natural exposure.
Biswas S; Choudhary P; Elias SC; Miura K; Milne KH; de Cassan SC; Collins KA; Halstead FD; Bliss CM; Ewer KJ; Osier FH; Hodgson SH; Duncan CJ; O'Hara GA; Long CA; Hill AV; Draper SJ
PLoS One; 2014; 9(9):e107903. PubMed ID: 25254500
[TBL] [Abstract][Full Text] [Related]
23. Safety and immunogenicity of DNA/modified vaccinia virus ankara malaria vaccination in African adults.
Moorthy VS; Pinder M; Reece WH; Watkins K; Atabani S; Hannan C; Bojang K; McAdam KP; Schneider J; Gilbert S; Hill AV
J Infect Dis; 2003 Oct; 188(8):1239-44. PubMed ID: 14551895
[TBL] [Abstract][Full Text] [Related]
24. Enhancing blood-stage malaria subunit vaccine immunogenicity in rhesus macaques by combining adenovirus, poxvirus, and protein-in-adjuvant vaccines.
Draper SJ; Biswas S; Spencer AJ; Remarque EJ; Capone S; Naddeo M; Dicks MD; Faber BW; de Cassan SC; Folgori A; Nicosia A; Gilbert SC; Hill AV
J Immunol; 2010 Dec; 185(12):7583-95. PubMed ID: 21098232
[TBL] [Abstract][Full Text] [Related]
25. Enhanced T-cell immunogenicity of plasmid DNA vaccines boosted by recombinant modified vaccinia virus Ankara in humans.
McConkey SJ; Reece WH; Moorthy VS; Webster D; Dunachie S; Butcher G; Vuola JM; Blanchard TJ; Gothard P; Watkins K; Hannan CM; Everaere S; Brown K; Kester KE; Cummings J; Williams J; Heppner DG; Pathan A; Flanagan K; Arulanantham N; Roberts MT; Roy M; Smith GL; Schneider J; Peto T; Sinden RE; Gilbert SC; Hill AV
Nat Med; 2003 Jun; 9(6):729-35. PubMed ID: 12766765
[TBL] [Abstract][Full Text] [Related]
26. Human vaccination against RH5 induces neutralizing antimalarial antibodies that inhibit RH5 invasion complex interactions.
Payne RO; Silk SE; Elias SC; Miura K; Diouf A; Galaway F; de Graaf H; Brendish NJ; Poulton ID; Griffiths OJ; Edwards NJ; Jin J; Labbé GM; Alanine DG; Siani L; Di Marco S; Roberts R; Green N; Berrie E; Ishizuka AS; Nielsen CM; Bardelli M; Partey FD; Ofori MF; Barfod L; Wambua J; Murungi LM; Osier FH; Biswas S; McCarthy JS; Minassian AM; Ashfield R; Viebig NK; Nugent FL; Douglas AD; Vekemans J; Wright GJ; Faust SN; Hill AV; Long CA; Lawrie AM; Draper SJ
JCI Insight; 2017 Nov; 2(21):. PubMed ID: 29093263
[TBL] [Abstract][Full Text] [Related]
27. Recombinant viral-vectored vaccines expressing Plasmodium chabaudi AS apical membrane antigen 1: mechanisms of vaccine-induced blood-stage protection.
Biswas S; Spencer AJ; Forbes EK; Gilbert SC; Holder AA; Hill AV; Draper SJ
J Immunol; 2012 May; 188(10):5041-53. PubMed ID: 22504652
[TBL] [Abstract][Full Text] [Related]
28. ChAd63-MVA-vectored blood-stage malaria vaccines targeting MSP1 and AMA1: assessment of efficacy against mosquito bite challenge in humans.
Sheehy SH; Duncan CJ; Elias SC; Choudhary P; Biswas S; Halstead FD; Collins KA; Edwards NJ; Douglas AD; Anagnostou NA; Ewer KJ; Havelock T; Mahungu T; Bliss CM; Miura K; Poulton ID; Lillie PJ; Antrobus RD; Berrie E; Moyle S; Gantlett K; Colloca S; Cortese R; Long CA; Sinden RE; Gilbert SC; Lawrie AM; Doherty T; Faust SN; Nicosia A; Hill AV; Draper SJ
Mol Ther; 2012 Dec; 20(12):2355-68. PubMed ID: 23089736
[TBL] [Abstract][Full Text] [Related]
29. Prime-boost immunization with adenoviral and modified vaccinia virus Ankara vectors enhances the durability and polyfunctionality of protective malaria CD8+ T-cell responses.
Reyes-Sandoval A; Berthoud T; Alder N; Siani L; Gilbert SC; Nicosia A; Colloca S; Cortese R; Hill AV
Infect Immun; 2010 Jan; 78(1):145-53. PubMed ID: 19858306
[TBL] [Abstract][Full Text] [Related]
30. DNA prime/Adenovirus boost malaria vaccine encoding P. falciparum CSP and AMA1 induces sterile protection associated with cell-mediated immunity.
Chuang I; Sedegah M; Cicatelli S; Spring M; Polhemus M; Tamminga C; Patterson N; Guerrero M; Bennett JW; McGrath S; Ganeshan H; Belmonte M; Farooq F; Abot E; Banania JG; Huang J; Newcomer R; Rein L; Litilit D; Richie NO; Wood C; Murphy J; Sauerwein R; Hermsen CC; McCoy AJ; Kamau E; Cummings J; Komisar J; Sutamihardja A; Shi M; Epstein JE; Maiolatesi S; Tosh D; Limbach K; Angov E; Bergmann-Leitner E; Bruder JT; Doolan DL; King CR; Carucci D; Dutta S; Soisson L; Diggs C; Hollingdale MR; Ockenhouse CF; Richie TL
PLoS One; 2013; 8(2):e55571. PubMed ID: 23457473
[TBL] [Abstract][Full Text] [Related]
31. Prime-boost vectored malaria vaccines: progress and prospects.
Hill AV; Reyes-Sandoval A; O'Hara G; Ewer K; Lawrie A; Goodman A; Nicosia A; Folgori A; Colloca S; Cortese R; Gilbert SC; Draper SJ
Hum Vaccin; 2010 Jan; 6(1):78-83. PubMed ID: 20061802
[TBL] [Abstract][Full Text] [Related]
32. Phase Ia clinical evaluation of the Plasmodium falciparum blood-stage antigen MSP1 in ChAd63 and MVA vaccine vectors.
Sheehy SH; Duncan CJ; Elias SC; Collins KA; Ewer KJ; Spencer AJ; Williams AR; Halstead FD; Moretz SE; Miura K; Epp C; Dicks MD; Poulton ID; Lawrie AM; Berrie E; Moyle S; Long CA; Colloca S; Cortese R; Gilbert SC; Nicosia A; Hill AV; Draper SJ
Mol Ther; 2011 Dec; 19(12):2269-76. PubMed ID: 21862998
[TBL] [Abstract][Full Text] [Related]
33. Transcriptional changes induced by candidate malaria vaccines and correlation with protection against malaria in a human challenge model.
Dunachie S; Berthoud T; Hill AV; Fletcher HA
Vaccine; 2015 Sep; 33(40):5321-31. PubMed ID: 26256523
[TBL] [Abstract][Full Text] [Related]
34. Enhanced T cell-mediated protection against malaria in human challenges by using the recombinant poxviruses FP9 and modified vaccinia virus Ankara.
Webster DP; Dunachie S; Vuola JM; Berthoud T; Keating S; Laidlaw SM; McConkey SJ; Poulton I; Andrews L; Andersen RF; Bejon P; Butcher G; Sinden R; Skinner MA; Gilbert SC; Hill AV
Proc Natl Acad Sci U S A; 2005 Mar; 102(13):4836-41. PubMed ID: 15781866
[TBL] [Abstract][Full Text] [Related]
35. Safety profile of the viral vectors of attenuated fowlpox strain FP9 and modified vaccinia virus Ankara recombinant for either of 2 preerythrocytic malaria antigens, ME-TRAP or the circumsporozoite protein, in children and adults in Kenya.
Bejon P; Peshu N; Gilbert SC; Lowe BS; Molyneux CS; Forsdyke J; Lang T; Hill AV; Marsh K
Clin Infect Dis; 2006 Apr; 42(8):1102-10. PubMed ID: 16575727
[TBL] [Abstract][Full Text] [Related]
36. Poor CD4
Zaric M; Marini A; Nielsen CM; Gupta G; Mekhaiel D; Pham TP; Elias SC; Taylor IJ; de Graaf H; Payne RO; Li Y; Silk SE; Williams C; Hill AVS; Long CA; Miura K; Biswas S
Front Immunol; 2021; 12():732667. PubMed ID: 34659219
[No Abstract] [Full Text] [Related]
37. Progress with viral vectored malaria vaccines: A multi-stage approach involving "unnatural immunity".
Ewer KJ; Sierra-Davidson K; Salman AM; Illingworth JJ; Draper SJ; Biswas S; Hill AV
Vaccine; 2015 Dec; 33(52):7444-51. PubMed ID: 26476366
[TBL] [Abstract][Full Text] [Related]
38. Differential immunogenicity of various heterologous prime-boost vaccine regimens using DNA and viral vectors in healthy volunteers.
Vuola JM; Keating S; Webster DP; Berthoud T; Dunachie S; Gilbert SC; Hill AV
J Immunol; 2005 Jan; 174(1):449-55. PubMed ID: 15611270
[TBL] [Abstract][Full Text] [Related]
39. A Plasmodium falciparum candidate vaccine based on a six-antigen polyprotein encoded by recombinant poxviruses.
Prieur E; Gilbert SC; Schneider J; Moore AC; Sheu EG; Goonetilleke N; Robson KJ; Hill AV
Proc Natl Acad Sci U S A; 2004 Jan; 101(1):290-5. PubMed ID: 14694197
[TBL] [Abstract][Full Text] [Related]
40. Immune responses in mice induced by prime-boost schemes of the Plasmodium falciparum apical membrane antigen 1 (PfAMA1)-based DNA, protein and recombinant modified vaccinia Ankara vaccines.
Miao J; Li X; Liu Z; Xue C; Bujard H; Cui L
Vaccine; 2006 Sep; 24(37-39):6187-98. PubMed ID: 16806600
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
